Academic Journal
أعرض في EDS

Secondary Prevention of Cervical Cancer : ASCO Resource–Stratified Guideline Update

التفاصيل البيبلوغرافية
العنوان: Secondary Prevention of Cervical Cancer : ASCO Resource–Stratified Guideline Update
المؤلفون: Shastri, Surendra S.
المساهمون: Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Medicina Interna. Grupo de Oncología. Centro Javeriano de Oncología, Murillo, Raul
سنة النشر: 2022
المجموعة: Pontificia Universidad Javeriana: Repositorio Institucional PUJ
الوصف: Q2 ; Q2 ; PURPOSE: To update resource-stratified, evidence-based recommendations on secondary prevention of cervical cancer globally. METHODS: American Society of Clinical Oncology convened a multidisciplinary, multinational Expert Panel to produce recommendations reflecting four resource-tiered settings. A review of existing guidelines, formal consensus-based process, and modified ADAPTE process to adapt existing guidelines was conducted. Other experts participated in formal consensus. RESULTS: This guideline update reflects changes in evidence since the previous update. Five existing guidelines were identified and reviewed, and adapted recommendations form the evidence base. Cost-effectiveness analyses provided indirect evidence to inform consensus, which resulted in ≥ 75% agreement. RECOMMENDATIONS: Human papillomavirus (HPV) DNA testing is recommended in all resource settings; visual inspection with acetic acid may be used in basic settings. Recommended age ranges and frequencies vary by the following setting: maximal: age 25-65 years, every 5 years; enhanced: age 30-65 years, if two consecutive negative tests at 5-year intervals, then every 10 years; limited: age 30-49 years, every 10 years; basic: age 30-49 years, one to three times per lifetime. For basic settings, visual assessment is used to determine treatment eligibility; in other settings, genotyping with cytology or cytology alone is used to determine treatment. For basic settings, treatment is recommended if abnormal triage results are obtained; in other settings, abnormal triage results followed by colposcopy is recommended. For basic settings, treatment options are thermal ablation or loop electrosurgical excision procedure; for other settings, loop electrosurgical excision procedure or ablation is recommended; with a 12-month follow-up in all settings. Women who are HIV-positive should be screened with HPV testing after diagnosis, twice as many times per lifetime as the general population. Screening is recommended at 6 weeks postpartum in basic ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: PDF; application/pdf
اللغة: English
تدمد: 2687-8941
Relation: 24; JCO Global Oncology; http://hdl.handle.net/10554/63777; https://doi.org/10.1200/GO.22.00217; instname:Pontificia Universidad Javeriana; reponame:Repositorio Institucional - Pontificia Universidad Javeriana; repourl:https://repository.javeriana.edu.co
DOI: 10.1200/GO.22.00217?role=tab
DOI: 10.1200/GO.22.00217
الاتاحة: http://hdl.handle.net/10554/63777
https://ascopubs.org/doi/abs/10.1200/GO.22.00217?role=tab
https://doi.org/10.1200/GO.22.00217
Rights: Atribución-NoComercial 4.0 Internacional ; http://creativecommons.org/licenses/by-nc/4.0/ ; http://purl.org/coar/access_right/c_abf2
رقم الانضمام: edsbas.6C48E950
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.6C48E950
938
3
Academic Journal
academicJournal
937.599182128906
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.6C48E950&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => http://hdl.handle.net/10554/63777# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edsbas&genre=article&issn=26878941&ISBN=&volume=&issue=&date=20220101&spage=&pages=&title=Secondary Prevention of Cervical Cancer : ASCO Resource–Stratified Guideline Update&atitle=Secondary%20Prevention%20of%20Cervical%20Cancer%20%3A%20ASCO%20Resource%E2%80%93Stratified%20Guideline%20Update&id=DOI:10.1200/GO.22.00217?role=tab [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Secondary Prevention of Cervical Cancer : ASCO Resource–Stratified Guideline Update )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Shastri%2C+Surendra+S%2E%22">Shastri, Surendra S.</searchLink> )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Medicina Interna. Grupo de Oncología. Centro Javeriano de Oncología<br />Murillo, Raul )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2022 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Pontificia Universidad Javeriana: Repositorio Institucional PUJ )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Q2 ; Q2 ; PURPOSE: To update resource-stratified, evidence-based recommendations on secondary prevention of cervical cancer globally. METHODS: American Society of Clinical Oncology convened a multidisciplinary, multinational Expert Panel to produce recommendations reflecting four resource-tiered settings. A review of existing guidelines, formal consensus-based process, and modified ADAPTE process to adapt existing guidelines was conducted. Other experts participated in formal consensus. RESULTS: This guideline update reflects changes in evidence since the previous update. Five existing guidelines were identified and reviewed, and adapted recommendations form the evidence base. Cost-effectiveness analyses provided indirect evidence to inform consensus, which resulted in ≥ 75% agreement. RECOMMENDATIONS: Human papillomavirus (HPV) DNA testing is recommended in all resource settings; visual inspection with acetic acid may be used in basic settings. Recommended age ranges and frequencies vary by the following setting: maximal: age 25-65 years, every 5 years; enhanced: age 30-65 years, if two consecutive negative tests at 5-year intervals, then every 10 years; limited: age 30-49 years, every 10 years; basic: age 30-49 years, one to three times per lifetime. For basic settings, visual assessment is used to determine treatment eligibility; in other settings, genotyping with cytology or cytology alone is used to determine treatment. For basic settings, treatment is recommended if abnormal triage results are obtained; in other settings, abnormal triage results followed by colposcopy is recommended. For basic settings, treatment options are thermal ablation or loop electrosurgical excision procedure; for other settings, loop electrosurgical excision procedure or ablation is recommended; with a 12-month follow-up in all settings. Women who are HIV-positive should be screened with HPV testing after diagnosis, twice as many times per lifetime as the general population. Screening is recommended at 6 weeks postpartum in basic ... )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => PDF; application/pdf )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 2687-8941 )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => 24; JCO Global Oncology; http://hdl.handle.net/10554/63777; https://doi.org/10.1200/GO.22.00217; instname:Pontificia Universidad Javeriana; reponame:Repositorio Institucional - Pontificia Universidad Javeriana; repourl:https://repository.javeriana.edu.co )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1200/GO.22.00217?role=tab )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1200/GO.22.00217 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://hdl.handle.net/10554/63777<br />https://ascopubs.org/doi/abs/10.1200/GO.22.00217?role=tab<br />https://doi.org/10.1200/GO.22.00217 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => Atribución-NoComercial 4.0 Internacional ; http://creativecommons.org/licenses/by-nc/4.0/ ; http://purl.org/coar/access_right/c_abf2 )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.6C48E950 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1200/GO.22.00217?role=tab ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Secondary Prevention of Cervical Cancer : ASCO Resource–Stratified Guideline Update [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Shastri, Surendra S. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Medicina Interna. Grupo de Oncología. Centro Javeriano de Oncología ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Murillo, Raul ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2022 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 26878941 ) [1] => Array ( [Type] => issn-locals [Value] => edsbas ) [2] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) ) ) ) ) )
IllustrationInfo